VEGF-A Human ELISA
| Other names: Vascular Permeability Factor, VPF, VEGF-A | Product of BioVendor | ||||
| Product: | Size: | ||||
|---|---|---|---|---|---|
| RBMS277/2R (regulatory status: RUO) | 96 wells (1 kit) | ||||
Files:
Datasheet PDF (RUO)MSDS (RUO)
|
|||||
Product details
Summary
VEGF is characterized by its highly specific mitogenic activity in endothelial cells and its angiogenic effect observed in vitro and in vivo. The VEGF family consists of four isoforms (A-D). VEGF-A is considered the most important of these with respect to tumor angiogenesis. and the splice variant isoforms VEGF121 and VEGF165 were found to be secreted by a wide spectrum of cell types, including smooth muscle cells, fibroblasts, epithelial cells, keratinocytes, macrophages, cardiac myocytes and various tumor cells. Inhibition of VEGF with a specific monoclonal antibody can suppress tumor growth in vivo.
Research topic
Cytokines and chemokines and related molecules
Assay format
Sandwich ELISA, Biotin-labelled antibody
Applications
Cell culture supernatant, Plasma-Citrate, Plasma-EDTA, Plasma-Heparin, Serum
Sample requirements
50 µl
Storage/Shipping
2–8°C
Calibration Curve
|
Calibration range
15.6 – 1 000 pg/ml
Limit of detection
7.9 pg/ml
Intra-assay
CV = 6.2%
Inter-assay
CV = 4.3%
By research topic:
By molecule:
Shopping cart
Your cart is empty.


